While some research indicates that the use of ACE-Is (or angiotensin receptor blockers) in older adults with AD is associated with a slower rate of cognitive decline [42, 53–55], other research cautions in the use of ACE inhibitors as they may interfere with Aβ clearance [40, 56, 57]. This evidence concerns the gene ACE and Alzheimer disease.